FDA Approves Prefilled Syringe Presentation for Shingles Vaccine

MONDAY, July 21, 2025 -- The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).

The existing vaccine consists of two...